Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients

BACKGROUND: The expression of HER2, estrogen (ER) and progesterone (PR) receptor can change during the course of the disease in breast cancer (BC). Therefore, reassessment of these markers at the time of disease progression might help to optimize treatment decisions. In this context, characterizatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Aktas, Bahriye, Kasimir-Bauer, Sabine, Müller, Volkmar, Janni, Wolfgang, Fehm, Tanja, Wallwiener, Diethelm, Pantel, Klaus, Tewes, Mitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960681/
https://www.ncbi.nlm.nih.gov/pubmed/27456970
http://dx.doi.org/10.1186/s12885-016-2587-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4960681/
https://www.ncbi.nlm.nih.gov/pubmed/27456970
http://dx.doi.org/10.1186/s12885-016-2587-4

Ejemplares similares